Michelle Fleetwood
Solutions Consultant
Clarivate
Academic researchers and institutions are leaders in discoveries that advance science and pave the way for new therapies to improve human health. Now more than ever, universities are expanding their focus beyond early R&D and towards clinical research to fully realize their innovation’s impact on patient populations.
Increase your chances of clinical success with access to the comprehensive data needed to select your patient populations, select biomarkers, define endpoints and evaluate potential adverse effects.
In this webinar recording, we draw upon analysis of recent clinical trial activity within academia to provide insights on how you can successfully transition your university’s early drug development efforts to the clinical setting.